Roche Narrows Pharma Pipeline Amid Push Into Obesity Market
In this article:
Roche is narrowing its pipeline to 11 disease areas and continuing to invest in a targeted way, said Teresa Graham, chief executive of Roche’s pharma division.
Advertisement